FDA Inspection 1233378 — Osteogene Tech Corp

Osteogene Tech Corp — FEI 3021912300

The FDA completed an inspection of Osteogene Tech Corp on Feb 14, 2024 in Norwood, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 14, 2024
Fiscal Year
2024
Product Type
Devices
Project Area
Compliance: Devices
Location
Norwood, NJ (United States)

Citations

IDCFRDescription
311921 CFR 820.75(b)Lack/Inad procedure-Monitoring/Control of Validated Proces

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.